Matriks Biotechnology
Matriks Biotechnology is a privately held Turkish biotech research company founded in 2002 and based in Ankara, conducting biotechnology R&D with an 11–50 employee team led by a microbiology professor founder. No commercial products, customers, or partnerships are publicly disclosed.
- Company typePrivate
- Founded2002
- HeadquartersAnkara
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Matriks Biotechnology does
Matriks Biotechnology (operating as Matriks Biotek) is a privately held biotechnology research company founded in 2002 and headquartered in Ankara, Turkey. Per available firmographic data, the company conducts research in biotechnology; no specific therapeutic area, platform technology, product pipeline, or research focus is disclosed in the source material. The firm is led by a Founder who is also a Professor of Microbiology, indicating an academic-anchored operating model consistent with university-affiliated or grant-funded R&D activity rather than a commercial product organization.
The company operates with an 11–50 employee headcount and maintains a web presence at matriksbiotek.com, though the publicly accessible webpage content consisted only of a verification/loading page at the time of data collection, providing no further substantive disclosure about products, services, customers, or technology. No products and services, no patents, no awards, no partnerships, no certifications, no management team beyond the founder, no funding rounds, no customer references, and no pricing model are documented in the input data. The absence of these standard data points means the business model, revenue mechanics, go-to-market motion, and customer segments are not determinable from public sources available.
Based on the available evidence, Matriks Biotechnology appears to function as a small, privately held Turkish biotech research entity, likely operating in a contract research, academic collaboration, or early-stage discovery capacity. The 20+ year operating history suggests institutional continuity, but the lack of disclosed commercial milestones, products, or partnerships indicates the firm has not reached scaled commercial visibility. Any assessment of competitive position, revenue, or growth requires additional primary-source information from the company itself.
Matriks Biotechnology firmographics
Firmographics- Name
- Matriks Biotechnology
- Website
- https://matriksbiotek.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Matriks Biotechnology is a privately held Turkish biotech research company founded in 2002 and based in Ankara, conducting biotechnology R&D with an 11–50 employee team led by a microbiology professor founder. No commercial products, customers, or partnerships are publicly disclosed.
- Ownership category
- akta.pro rank
Matriks Biotechnology industry classification
Industry- Product category
- Biotechnology Research
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
Keywords
Where Matriks Biotechnology is headquartered
LocationHeadquarters
- HQ city
- Ankara
Markets served
Matriks Biotechnology business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D
Matriks Biotechnology product offering
Product offeringCore offering
Matriks Biotechnology (Matriks Biotek) is a Turkey-based biotechnology company that conducts research in biotechnology and microbiology. The firm is positioned as a research-oriented biotech operation supporting scientific work in the life sciences domain.
Differentiator
Problem solved
Functional benefit
Products and services
- Biotechnology Research Services
Companies that use Matriks Biotechnology
Customer profileIdeal customer profiles1 record
Matriks Biotechnology technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Matriks Biotechnology competitors and assessment
Company assessmentBroad incumbents
- Eurofins Scientific: A global leader in bioanalytical testing and laboratory services across life sciences. Operates broadly across pharma, food, and environmental testing — overlapping with Matriks as a lab-services provider but at vastly greater scale and scope.
- WuXi AppTec: A leading global R&D and manufacturing services platform serving the pharmaceutical and biotech industries. Comparable as a one-stop research services provider, though operating at a vastly larger scale and breadth.
- Charles River Laboratories: A major CRO offering research models, preclinical services, and biologics CDMO capabilities. Comparable to Matriks in providing research services to biotech clients, but operates globally with a much broader service portfolio.
Direct peers
- Syngene International: An India-based CRO/CDMO providing integrated research, development, and manufacturing services to pharmaceutical and biotechnology companies. Comparable business model focused on outsourced biotech research services.
- Aragen Life Sciences: A global contract research organization offering discovery, development, and manufacturing services across biologics and small molecules. Comparable to Matriks as a CRO serving biotech R&D clients, though at significantly larger scale.
- Curia: A CDMO and contract research services provider focused on small molecules and biologics from research through manufacturing. Directly comparable as a CRO/CDMO serving biotech R&D needs.
Regional players
- Abdi İbrahim: Turkey's largest pharmaceutical company, providing drug development and manufacturing in the same geography as Matriks. Comparable as a Turkish life-sciences company with R&D operations, though focused on pharmaceutical products rather than research services.
- DEVA Holding: A Turkish pharmaceutical manufacturer with R&D operations producing human medicinal products. Comparable as a Turkish life-sciences operator, though primarily in branded pharmaceuticals rather than biotech contract research.
Market position
Strengths2 records
Weaknesses3 records
Competitive moat1 record
Key risks4 records
Key highlights3 records
Customer concentration
Matriks Biotechnology social profiles
Digital presenceMatriks Biotechnology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Matriks Biotechnology leadership team
Management profileNumber of profiles
Profiles1 record
Matriks Biotechnology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Matriks Biotechnology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Matriks Biotechnology
What does Matriks Biotechnology do?
Matriks Biotechnology (Matriks Biotek) is a Turkey-based biotechnology company that conducts research in biotechnology and microbiology. The firm is positioned as a research-oriented biotech operation supporting scientific work in the life sciences domain.
Is Matriks Biotechnology a public or private company?
Matriks Biotechnology is a private company. It is classified as unknown and is currently operating.
When was Matriks Biotechnology founded?
Matriks Biotechnology was founded in 2002. It employs 11 to 50 people.
Where is Matriks Biotechnology based?
Matriks Biotechnology is headquartered in Ankara.
Who are Matriks Biotechnology's main competitors?
Broad incumbents on record are Eurofins Scientific, WuXi AppTec and Charles River Laboratories. Direct peers are Syngene International, Aragen Life Sciences and Curia. Regional players are Abdi İbrahim and DEVA Holding.
Does Matriks Biotechnology have an API?
No public API is recorded for Matriks Biotechnology.
What industry is Matriks Biotechnology in?
Matriks Biotechnology's product category is Biotechnology Research. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays). Its NAICS code is 541714 and its SIC code is 8731.